{"id":115616,"date":"2020-04-09T07:30:08","date_gmt":"2020-04-09T17:30:08","guid":{"rendered":"https:\/\/www.hawaii.edu\/news\/?p=115616"},"modified":"2020-04-14T09:41:50","modified_gmt":"2020-04-14T19:41:50","slug":"tool-for-non-hodgkin-lymphoma","status":"publish","type":"post","link":"https:\/\/www.hawaii.edu\/news\/2020\/04\/09\/tool-for-non-hodgkin-lymphoma\/","title":{"rendered":"糖心视频<\/abbr> reveals screening tool for non-Hodgkin Lymphoma in children"},"content":{"rendered":"Reading time: <\/span> < 1<\/span> minute<\/span><\/span>
\"bruce
Bruce Shiramizu<\/figcaption><\/figure>\n

Scientists at the University of Hawaiʻi<\/span> at M\u0101noa<\/a> have discovered a novel method of diagnosing non-Hodgkin lymphoma, a group of cancers that start in cells called lymphocytes, which are part of the body\u2019s immune system. <\/p>\n

Currently, there are no widely recommended screening tests for non-Hodgkin lymphoma, which is usually diagnosed through invasive surgical or needle biopsies, or removal of living tissue for examination. <\/p>\n

This new study, published in SciMedicine<\/em><\/a>, suggests the use of Raman spectroscopy technology as an initial step to determine if and when a biopsy would be necessary.<\/p>\n

\"bruce<\/p>\n

The study is led by Bruce Shiramizu<\/strong>, pediatrician researcher at the John A. Burns School of Medicine<\/a> (JABSOM<\/abbr>) and senior author of the paper. Shiramizu describes their findings as a repurposing of technology that has been used for the Department of Defense in remotely identifying chemicals such as explosives using a laser technique.<\/p>\n

“We partnered with an investigator with a physics background to design a way to use a hand-held probe to identify different types of pediatric non-Hodgkin lymphoma tissues,” said Shiramizu. He adds, “the importance of this work is to be able to use the hand-held probe as a screening or diagnostic tool for real-time assessment of a mass that might be a tumor.”<\/p>\n

“This work in characterizing malignant cells has future diagnostic implications as a non-invasive initial tissue assessment in children with potential malignancies,” said Melissa Agsalda-Garcia<\/strong>, researcher at JABSOM<\/abbr>\u2019s Hawai\u02bbi Center for AIDS<\/a> and first-author of the paper.<\/p>\n

This study is being supported by the St. Baldrick\u2019s Foundation, the largest private funder of childhood cancer research grants, through multiple grants totaling $113,000.<\/p>\n","protected":false},"excerpt":{"rendered":"

Bruce Shiramizu and Melissa Agsalda-Garcia suggest a novel screening tool for non-Hodgkin Lymphoma in children.<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[218,978,31,1363,9],"class_list":["post-115616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research","tag-cancer","tag-hawaii-center-for-aids","tag-john-a-burns-school-of-medicine","tag-manoa-research","tag-uh-manoa","entry","has-media"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t